Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features

NCT07461805 · tracked via the Priya Life Science Spain tracker

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase

Observational

Started

2025-11-04

Last updated

2026-03-10

Condition(s) studied

Type 1 Diabetes Mellitus

Study summary

The goal of this observational study is to characterize different subgroups among patients with type 1 diabetes. The main research question is:

Are there distinct subtypes among people with type 1 diabetes?

Participants will be invited to take part in the study by allowing access to their health data. They will not be required to undergo any additional examinations, tests, visits, or interventions.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Individuals with type 1 diabetes (T1D) aged 18 years or older. * T1D individuals expected to have regular follow-up at the Endocrinology and Nutrition Department of Hospital de la Santa Creu i Sant Pau. * Users of continuous glucose monitoring (CGM) systems for at least the last 6 months of 2024. * Willingness and ability to provide written informed consent to participate in the study (by the patient or his/her representative). Exclusion Criteria: * Presence of severe comorbidities or medical conditions that, in the investigator's judgment, could interfere with participation in the study or the interpretation of results. This circumstance is expected to be exceptional, as the study aims to be as inclusive as possible.

Primary outcome measure(s)

Type 1 diabetes clusters — Subgroups defined based on data from the year 2024.
Differentiated groups of people with type 1 diabetes defined through the analysis of clinical, analytical, and glucometric variables.

Trial sites (1)

Facility	City	Region	Status
Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona 08041	Barcelona	Barcelona	Recruiting

More Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials in Spain

Comprehensive Assessment of First Trimester Pregnancy Loss Recruiting

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective. Recruiting

Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study Recruiting

Body Composition Assessment and Monitoring in Inflammatory Bowel Disease Recruiting

Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia Active, not recruiting

Other trials for the same condition

Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes Starting soon

Polycystic Ovary Syndrome in Type 1 Diabetes Recruiting

Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS) Active, not recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07461805 on ClinicalTrials.gov ↗ ← All trials in Spain